Avid Bioservices Inc (CDMO)

[nuke661]

FF,
I'm thinking, based on the info revenue monster posted a couple days ago that J Shan is still scheduled for the Dec. 5 presentation and will present if the 2nd line trial issue is resolved (Don't know why that post was deleted but it sounded credible to me) that Peregrine is keeping their options open and must feel there is a chance to have resolution by Dec 5. If they kept their options open for the presentation I'm thinking they may have kept their options open with the FDA and the Dec meeting they wanted to have before this mess happened. Meaning that they probably didn't cancel the meeting and if they have a resolution by 12-5 they would still be on track to have the EOP II meeting in Dec. Might just be wishful thinking but why wouldn't they keep the option open until they were absolutely sure there was no benefit to have the meeting. I don't ever remember that they said they canceled any meetings with the FDA; for that matter I don't ever remember them stating when they have specific scheduled dates for meetings with the FDA.